Morgan Stanley Boosts Align Technology (NASDAQ:ALGN) Price Target to $169.00

Align Technology (NASDAQ:ALGN) had its target price increased by Morgan Stanley from $154.00 to $169.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has an “equal weight” rating on the medical equipment provider’s stock. Morgan Stanley’s price objective would indicate a potential upside of 4.77% from the stock’s previous close.

Several other equities research analysts have also recently weighed in on ALGN. Leerink Partners upped their target price on Align Technology from $189.00 to $210.00 and gave the stock an “outperform” rating in a report on Thursday, January 22nd. Piper Sandler restated an “overweight” rating and issued a $220.00 price objective on shares of Align Technology in a report on Thursday. Mizuho upped their price objective on shares of Align Technology from $170.00 to $200.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 20th. Needham & Company LLC reissued a “hold” rating on shares of Align Technology in a research report on Thursday, October 30th. Finally, Jefferies Financial Group boosted their price target on shares of Align Technology from $140.00 to $155.00 in a report on Thursday, October 30th. Six equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $182.73.

Align Technology Trading Up 2.7%

Shares of Align Technology stock opened at $161.30 on Thursday. The firm has a market cap of $11.57 billion, a PE ratio of 31.26, a PEG ratio of 1.76 and a beta of 1.84. The stock has a 50 day moving average of $161.89 and a 200 day moving average of $148.59. Align Technology has a 12 month low of $122.00 and a 12 month high of $232.20.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $3.29 EPS for the quarter, beating the consensus estimate of $2.99 by $0.30. The business had revenue of $1.05 billion during the quarter, compared to analyst estimates of $1.03 billion. Align Technology had a net margin of 9.50% and a return on equity of 13.96%. Align Technology’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter last year, the business earned $2.44 earnings per share. As a group, equities research analysts forecast that Align Technology will post 7.98 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Align Technology

Hedge funds have recently made changes to their positions in the company. Sentry Investment Management LLC boosted its holdings in Align Technology by 73.1% during the third quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 79 shares in the last quarter. Steigerwald Gordon & Koch Inc. acquired a new position in shares of Align Technology in the third quarter worth about $26,000. Rothschild Investment LLC boosted its stake in shares of Align Technology by 140.3% during the 2nd quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 87 shares in the last quarter. True Wealth Design LLC boosted its stake in shares of Align Technology by 7,650.0% during the 2nd quarter. True Wealth Design LLC now owns 155 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 153 shares in the last quarter. Finally, Independence Bank of Kentucky grew its position in shares of Align Technology by 77.7% during the 4th quarter. Independence Bank of Kentucky now owns 183 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 80 shares during the period. 88.43% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Align Technology

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q4 results beat consensus: ALGN reported $3.29 EPS vs. $2.99 expected and $1.048B revenue vs. ~$1.03B expected; revenue was up ~5.3% year‑over‑year, and EPS rose materially vs. prior year — a clear near‑term fundamental catalyst. Business Wire — Q4 Results
• Positive Sentiment: Management set a 2026 revenue target (~3%–4%) and cited momentum from DSOs (dental service organizations) plus digital innovation (iTero scanners, software) as drivers — this gives investors a visible growth cadence beyond the quarter. Seeking Alpha — 2026 Outlook
• Positive Sentiment: Analyst support: William Blair reiterated a Buy rating, stating resilient core markets and DSO‑driven growth justify a bullish stance — analyst backing can amplify buying after an earnings beat. TipRanks — William Blair Buy Rating
• Neutral Sentiment: Q1 guidance roughly in line with Street: management’s near‑term revenue guide was about in line with consensus, limiting downside from a disappointing outlook but also capping upside surprise potential. Reuters — Guidance Note
• Neutral Sentiment: Options and trading flow showed elevated activity around the print — increased options volume can amplify intraday moves but doesn’t change fundamentals. Traders should watch implied vol and open interest for short‑term risk. Benzinga — Options Flow
• Neutral Sentiment: Management materials and the earnings slide deck are available for deeper detail on segment trends, margins and regional performance — useful for investors doing a post‑earnings read. Seeking Alpha — Presentation

Align Technology Company Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.